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A 22q11.2 Deletion That Excludes UFD1L and
CDC45L in a Patient with Conotruncal and
Craniofacial Defects
To the Editor:
Microdeletions of chromosome 22q11.2 occur with a
high frequency in the general population, with an esti-
mated incidence of 1/3,000–1/4,000 (Burn and Good-
ship 1996). They have been shown to be associated with
the malformation phenotypes of velocardiofacial syn-
drome (VCFS [MIM 192430]), DiGeorge syndrome
(DGS [MIM 188400]), and conotruncal anomaly face
syndrome (CAFS [MIM 217095]) (Emanuel et al.
1999a). Deletions of this region have also been dem-
onstrated in some patients with the autosomal dominant
form of Opitz G/BBB syndrome (MIM 145410)
(McDonald-McGinn et al. 1995). Significant phenotypic
overlap is found among these entities, including cono-
truncal cardiac defects, craniofacial anomalies, learning
disabilities, and cleft palate. The spectrum of clinical
findings shows considerable variability, even within fam-
ilies (McLean et al. 1993).
Although the overwhelming majority (185%) of pa-
tients have deletions of the same ∼3-Mb region (Emanuel
et al. 1999a), several reports have described patients
with atypical, shorter deleted segments nested within the
large typically deleted region (TDR) (Levy et al. 1995;
Kurahashi et al. 1996; O’Donnell et al. 1997; McQuade
et al. 1999). Recently, a small, 20-kb deletion within the
TDR was reported in a patient with a classic VCFS/DGS
phenotype. This smaller deletion disrupts the UFD1L
andCDC45L genes, the products of which (in particular,
UFD1L) have been suggested to play important roles in
craniofacial and cardiac development resulting in the
phenotype (Shaikh et al. 1999; Yamagishi et al. 1999).
However, several of the aforementioned patients (some
of whom have cardiac and craniofacial defects) have
deletions that do not include the region containing these
genes. These observations suggest that additional se-
quences within the TDR affect early craniofacial and
cardiac morphogenesis. Additionally, a patient with fea-
tures of DGS and with a microdeletion that falls outside
the TDR but that does not overlap with any of the
known deletions was recently described (Rauch et al.
1999). This patient had craniofacial abnormalities and
an interrupted aortic arch (type B) with truncus arter-
iosus, the same defect seen in the patient described by
Yamagishi et al. (1999). The report by Rauch et al. fur-
ther emphasizes the likelihood that the 22q11.2-related
cardiac defects are unlikely to result from defects in-
volving a single gene within the TDR.
We have identified a patient, CH98-18 (Emanuel et
al. 1998), with a novel deletion of chromosome 22q11.2.
His deletion is distal to the usual 3-Mb deletion found
in most patients with VCFS and appears to overlap with
a portion of the deleted region described by Rauch et
al. (1999). The deletion does not overlap with any
of the previously described “minimal critical regions”
for VCFS/DGS. The patient was born to a 33-year-old
mother at 35 wk gestation. The pregnancy was com-
plicated by a weight gain of 70 lbs and premature rup-
ture of membranes. The baby was delivered by cesarean
section, because of breech presentation, with Apgar
scores of 7 at 1 min and 8 at 5 min. Physical examination
at birth was notable for an appropriate-for-gestational-
age infant with hypertelorism, posteriorly rotated ears,
micrognathia, a loud cardiac murmur, hypospadias, de-
scended testes, single palmar creases, and 5th-finger cli-
nodactyly bilaterally. Renal and cranial ultrasounds
were normal. Echocardiography showed the presence of
truncus arteriosus type II and a ventricular septal defect.
Borderline hypocalcemia was also present. The patient
had surgical repair of his truncus arteriosus at age 3 wk
and a replacement graft at age 7 mo.
Motor development was normal. The patient sat at
age 6 mo and walked at age 14 mo. However, he had
expressive-speech delay, speaking his first words at age
21 mo. At age 26 mo, he had speech appropriate for an
18-month-old. During a recent physical examination at
age 26 mo (fig. 1), short stature, microcephaly, a prom-
inent glabella, partially attached earlobes, a broad nasal
bridge, a broad nasal tip with a crease, hypoplastic nasal
alae, anteverted nares, a featureless philtrum, a down-
turned mouth, a bifid uvula, and normal hearing and
vision were noted. Endocrine evaluation including thy-
roid-function and growth-hormone panels was unre-
markable. Immunologic studies including surface mark-
ers for T-cell, B-cell, and NK lineages, myeloid markers,
leukocyte adhesion, and Wiskott-Aldrich–associated
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Figure 1 Photographs of patient CH98-18 at age 26 mo. Note hypertelorism, broad nose, and micrognathia.
proteins were all normal. Proliferative responses tomito-
gen-stimulation tests were also normal, as were function-
al-antibody responses.
GTG-banded chromosomes prepared directly from
peripheral-blood lymphocytes showed a normal 46,XY
karyotype, and FISH was negative for a deletion when
the N25 (Oncor) probe was used (fig. 2A). In addition,
CH98-18 did not have a deletion for a number of other
cosmid-based FISH markers within the TDR, including
D22S788, ZNF74, HCF2, and cHKAD26 (fig. 2B)
(Emanuel et al. 1998). With the exception of cHKAD26,
cosmids used for FISH were isolated by colony hybrid-
ization from the chromosome 22–specific cosmid library
(LL22NCO3) generated at the Lawrence LivermoreLab-
oratories. The cosmid that contains the cHKAD26 locus
was provided by the Japanese Cancer Research Re-
sources Bank. A cosmid, 83C5, containing the portions
of the UFD1L and CDC45L genes deleted in the patient
of Yamagishi et al. (Shaikh et al. 1999) was also used
for FISH and was not deleted (data not shown). We
determined that a cosmid located distally in the TDR
(107D7) was not deleted (fig. 2B). Because the clinical
findings in the patient, including truncus arteriosus, a
bifid uvula, hypoplastic alar nasi, and a history of hy-
pocalcemia, were consistent with those seen in VCFS,
additional analysis was undertaken. Use of a series of
cosmid and bacterial artificial-chromosome–derived
probes for FISH demonstrated, initially with a cosmid
for locus D22S801, that a deletion adjacent to the TDR
was present (fig. 2A,b and B). Both of CH98-18’s par-
ents were analyzed by FISH with the cosmid for
D22S801 and were found not to have a deletion, indi-
cating a de novo origin of the deletion.
We and others have implicated blocks of duplicated
DNA sequence containing BCRL and GGTL elements
in the mechanism etiologic for the 22q11.2 deletions
(Emanuel et al. 1998, 1999b; Edelmann et al. 1999).
We predicted, on the basis of the presence of additional
BCRL and GGTL duplicated sequences distal to the
TDR, that CH98-18’s deletion might involve one of
these elements. Thus, the extent of his deletionwas inves-
tigated on the basis of the map of the region immediately
distal to the TDR. This region contains the immuno-
globulin-l light-chain locus (IGLL), within which are
located BCRL4 and a copy of GGTL (Kawasaki et al.
1995). The IGLL locus has been completely character-
ized in a cosmid contig (Kawasaki et al. 1995) and has
been sequenced (Kawasaki et al. 1997). Using the cosmid
and sequence reagents, wemoved distally fromD22S801
(LN80) into the IGLL to detect the deletion end point
(DEP). To insure that the germline genomic configura-
tion of this region was being investigated, all studies
were performed on cultured peripheral-blood lympho-
cytes. We determined that, although cosmid 61E11 is
deleted, 102D1 is the first cosmid not deleted in CH98-
18 (fig. 2A and B). In the sequenced contig, these cos-
mids are separated by ∼40 kb that contain BCRL4 and
GGTL. Using DNA sequence information for 102D1,
we designed PCR-based 2.0-kb FISH probes and deter-
mined that both ends of this cosmid, which is immedi-
ately distal to the BCRL4/GGTL duplicated sequence in
the IGLL locus, are present (GenBank). These probes are
present, then, on both homologues. Results for one of
these probes are shown in figure 2A. Thus, our patient’s
telomeric DEP involves a duplicated-sequence block that
contains BCRL4 and GGTL sequences. The presence of
a DEP in the vicinity of the BCRL4/GGTL duplication
suggests unequal crossing-over in the formation of the
patient’s deletion. Additional cosmids distal to 102D1
were examined by FISH, and all were present on both
Figure 2 A, Dual-color FISH for DEP positioning in patient CH98-18. All metaphase spreads are hybridized with a control cosmid
containing the distal marker D22S39. D22S39 was biotinylated and detected with avidin-FITC to identify chromosome 22 (seen at the telomeric
end of chromosome 22, in all panels [green]). Most test cosmids were labeled and detected with digoxigenin-rhodamine–conjugated probes
(red), except D22S801, which was biotinylated and then detected with avidin-FITC (green). In a, N25 (Oncor) is shown (red) and is present
on both homologues (arrows). In b, cohybridization with two test cosmids, D22S36 (red) and D22S801 (green), shows them as overlapping
signals on the normal chromosome 22 (arrow), with the control signal (D22S39) (green). Absence of the FITC test signal on the other chromosome
22 (arrowhead) indicates a deletion of D22S801. In c, cosmid 11E6 (red) is not detected on one of the chromosomes 22 (arrowhead) but is
present on the normal homologue (arrow). In d, a PCR-derived probe from the distal end of cosmid 102D1 (red) is present on both chromosome
22 homologues (arrows). The 102D1 probe was generated by PCR using primers designed from sequence (for nucleotides 34424–36498)
available in GenBank (accession number D86994). The PCR product was cloned by ligation into a TA cloning vector (Invitrogen), and the
resultant plasmid was labeled by nick translation. B, Composite breakpoint map of 22q11.2, depicting the relative locations of several reported
atypical deletions (turquoise bars). The typical deletion is also shown (lavender bar). Within the map of the TDR, genes and markers that
identify the cosmids used for FISH experiments are depicted. Addresses of cosmids from the IGLL map (Kawasaki et al. 1995) that were used
for FISH experiments are also shown. Individual duplicated-sequence blocks are also shown (dark blue). The IGLL locus is indicated by the
bracket below the map. The cosmids from within the IGLL locus that are used for FISH are indicated on the top line over the region shaded
in light red.
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homologues (data not shown). These cosmids included
48A11, 9C5, 75C12, and 81A12 from the previously
published IGLL contig (Kawasaki et al. 1995), as well
as the commercially available M-BCR probe (Oncor).
The region distal to 102D1, extending to the M-BCR
probe, was deleted in the family described by Rauch et
al. (1999).
Thus, our patient has a novel deletion of chromosome
22q11.2 and features of VCFS, including hypoplastic
alar nasi, a bifid uvula, and truncus arteriosus, a cardiac
lesion characteristic of the deletion. In a previous study,
∼35% of patients with persistent truncus arteriosuswere
demonstrated to have standard deletions of 22q11.2
(Goldmuntz et al. 1998). To determine whether CH98-
18’s distal deletion might be related to his particular
heart defect, we subsequently analyzed 15 other patients
with truncus arteriosus who did not have a deletion
when the N25 probe was used. None of these patients
had a deletion of D22S801 (B. S. Emanuel, unpublished
data). Furthermore, patient CH98-18 has hypertelorism,
anteverted nares, a grooved nasal tip, and hypospadias,
which, although reported in VCFS, are more commonly
described in Opitz G/BBB syndrome (Robin et al. 1996).
Opitz G/BBB is a heterogeneous disorder first described
in 1969 (Opitz et al. 1969a, 1969b) and linked to the
X chromosome (MIM 300000) and 22q11 (Robin et al.
1995). The X-linked form has subsequently been asso-
ciated with mutations of the MID1 gene located on
Xp22 (Quaderi et al. 1997; Gaudenz et al. 1998). Pa-
tients with features of Opitz G/BBB and an autosomal
dominant mode of inheritance have also been reported
(Opitz 1987; Robin et al. 1995). Because of phenotypic
overlap with the 22q11.2 deletion, several patients were
assayed for and were found to have deletions of 22q11.2
(McDonald-McGinn et al. 1995). These patients all had
the typical 3-Mb deletion commonly seen in VCFS/DGS.
Analysis of several additional Opitz G/BBB cases with-
out TDR deletions has failed to demonstrate a distal
deletion similar to the one described in the present report
(B. S. Emanuel, unpublished data).
Therefore, the deletion reported here is atypical of that
seen with a VCFS/DGS phenotype, and it is also atypical
of those deletions that have been seen with autosomal
dominant Opitz syndrome. It is notable that CH98-18’s
deletion does not encompass the region containing the
UFD1L and CDC45L genes. He does, however, like the
patient described by Rauch et al., have a cardiac defect
similar to that seen in the patient described by Yamagishi
et al. These cases with deletions distal to the TDR argue
against the hypothesis that UFD1L and CDC45L alone
are sufficient to cause the cardiac defect and craniofacial
features typically seen in VCFS/DGS. It is more likely
that our patient’s phenotype is the result of haploinsuf-
ficiency of other genes located in this distal deleted re-
gion, which may, perhaps, function with UFD1L and
CDC45L in a common developmental pathway. Alter-
natively, our patient’s deletion raises the possibility of
either a “position effect” on genes within the TDR or a
more complex mechanism etiologic for features of the
disorder, because his deletion is distal to the TDR and
appears not to include any of the genes described within
the TDR.
Our patient’s deletion is contained within the deletion
described by Rauch et al. (1999); however, the pheno-
types are not concordant. Both patient CH98-18 and
the proband from the study by Rauch et al. have per-
sistent truncus arteriosus. Nonetheless, there are no signs
of Optiz G/BBB in any members of the family (including
the proband) described by Rauch et al. However, since
all of the subjects described in their report were female,
only the laryngoesophageal anomalies and hypertelor-
ism would be pertinent findings.
Thus, it becomes apparent, when one is studying such
“atypical” patients, that delineating a minimal critical
region as causal for the VCFS/DGS phenotype spectrum
may be of limited applicability. Findings from this pa-
tient and the others discussed here imply that disruption
of more than one gene most likely contributes to the
phenotype. Further definition of the mechanisms that
lead to these deletions and of the involvement of the
duplicated-sequence blocks found in the region (Eman-
uel et al. 1998; Edelmann et al. 1999) would enable a
greater understanding of (1) why these deletions and
their subsequent phenotypes are so frequently encoun-
tered and (2) the role that sequences on 22q11.2 have
in their etiology.
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